Related references
Note: Only part of the references are listed.Challenges and Promise of a Hepatitis C Virus Vaccine
Andrea L. Cox
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion
Gisa Gerold et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors
Yixuan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action
Xinbei Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label study
Jordan J. Feld et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1
Zongyi Hu et al.
CELL CHEMICAL BIOLOGY (2020)
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Raymond T. Chung et al.
CLINICAL INFECTIOUS DISEASES (2018)
Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018
Maria C. Sorbo et al.
DRUG RESISTANCE UPDATES (2018)
Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment
Amit Goel et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Global epidemiology and burden of HCV infection and HCV-related disease
Aaron P. Thrift et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
Shanshan He et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action
Noemie Calland et al.
JOURNAL OF VIROLOGY (2015)
Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection
Shanshan He et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
G Protein- Coupled Receptor Signaling Analysis Using Homogenous Time-Resolved Forster Resonance Energy Transfer ( HTRF ) Technology
Lenea Norskov-Lauritsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry
Noemie Calland et al.
HEPATOLOGY (2012)
Reductive methylation of primary and secondary amines and amino acids by aqueous formaldehyde and zinc
Renato A. da Silva et al.
TETRAHEDRON LETTERS (2007)
In-Cell Western assay: a new approach to visualize tissue factor in human monocytes
EM Egorina et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Complete replication of hepatitis C virus in cell culture
BD Lindenbach et al.
SCIENCE (2005)
Share Paper
